Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,525,194 papers from all fields of science
Search
Sign In
Create Free Account
naftopidil
Known as:
1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Broader (6)
Adrenergic alpha-Antagonists
Antihypertensive Agents
Calcium Channel Blockers
Naphthalenes
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Propiverine increases urethral wall catecholamine levels and bladder leak point pressure in rats
S. Nishijima
,
K. Sugaya
,
K. Kadekawa
,
Katsuhiro Ashitomi
,
T. Ueda
,
Hideyuki Yamamoto
International journal of urology
2016
Corpus ID: 21902232
To investigate whether propiverine has a noradrenaline re‐uptake inhibitor and whether it acts on the lumbosacral cord or the…
Expand
2013
2013
α1D/A‐adrenoceptor antagonist naftopidil for the male lower urinary tract symptoms associated with benign prostatic hyperplasia: Efficacy of dose increase therapy
S. Yamaguchi
,
Hiroaki Osanai
,
A. Numata
,
Masaki Watanabe
,
H. Kakizaki
International journal of urology
2013
Corpus ID: 43630450
To examine the efficacy of dose increase therapy in patients with lower urinary tract symptoms associated with benign prostatic…
Expand
2010
2010
Long-term treatment and prognostic factors of α1-blockers for lower urinary tract symptoms associated with benign prostatic hyperplasia: A pilot study comparing naftopidil and tamsulosin…
Y. Kawachi
,
Toru Sakurai
,
+4 authors
O. Maruyama
Scandinavian Journal of Urology and Nephrology
2010
Corpus ID: 8883546
Abstract Objective. This study evaluated the 5-year failure rate of naftopidil (NAF) or tamsulosin hydrochloride (TAM) in lower…
Expand
2009
2009
Prostate growth inhibition by subtype‐selective alpha1‐adrenoceptor antagonist naftopidil in benign prostatic hyperplasia
Y. Kojima
,
S. Sasaki
,
+5 authors
K. Kohri
The Prostate
2009
Corpus ID: 206397320
Recently, alpha1‐adrenoceptors (α1‐ARs) have been reported to play a prominent role in the growth of a variety of cells; however…
Expand
2008
2008
In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.
Y. Noguchi
,
Akiyoshi Ohtake
,
Masanori Suzuki
,
M. Sasamata
European Journal of Pharmacology
2008
Corpus ID: 20958274
2006
2006
Effect of tamsulosin on spontaneous bladder contraction in conscious rats with bladder outlet obstruction: comparison with effect on intraurethral pressure.
Akiyoshi Ohtake
,
M. Ukai
,
+7 authors
K. Miyata
European Journal of Pharmacology
2006
Corpus ID: 38076322
1997
1997
In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine.
N. A. Alarayyed
,
M. Cooper
,
B. Prichard
,
D. Betteridge
,
C. Smith
British Journal of Clinical Pharmacology
1997
Corpus ID: 19547743
AIMS The aim of the study was to obtain further information regarding the modes of action of doxazosin, naftopidil and nifedipine…
Expand
1991
1991
[3H]bunazosin, a novel selective radioligand of alpha 1 adrenoceptors in human prostates.
S. Yamada
,
M. Suzuki
,
+4 authors
K. Kawabe
Journal of Urology
1991
Corpus ID: 5935217
1991
1991
Characterization of Ca2+-Antagonistic Effects of Three Metabolites of the New Antihypertensive Agent Naftopidil, (naphthyl)Hydroxy‐Naftopidil, (phenyl)Hydroxy‐Naftopidil and O-Desmethyl‐Naftopidil
M. Grundke
,
H. Himmel
,
E. Wettwer
,
H. O. Barbe
,
U. Ravens
Journal of Cardiovascular Pharmacology
1991
Corpus ID: 38246911
The newly developed antihypertensive agent naftopidil blocks α1-adrenoceptors and inhibits Ca2+ entry via potential-dependent…
Expand
1991
1991
Naftopidil, a New α‐Adrenoceptor Blocking Agent with Calcium Antagonistic Properties: Characterization of Ca2+ Antagonistic Effects
H. Himmel
,
H. Glossmann
,
U. Ravens
Journal of Cardiovascular Pharmacology
1991
Corpus ID: 20843831
The newly developed antihypertensive agent naftopidil blocks α1-adrenoceptors and inhibits Ca2+ entry via potential-dependent…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE